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Abstract
Background: The resazurin microtiter assay (classic REMA), a colorimetric liquid culture-based drug susceptibility
assay for Mycobacterium tuberculosis (MTB), has been endorsed by the World Health Organization. The assay requires
8-16 days to obtain results, delaying management of drug resistant tuberculosis patients. A modified REMA which
allows results in as little as 24 hours for bacterial strains, has been developed and validated using Staphylococcus
aureus, but has not yet been evaluated for MTB. Therefore we assessed the performance of the modified REMA
for rifampicin (RIF) and isoniazid (INH) susceptibility, using the classic REMA as the reference standard. We also
compared simplicity (from the technicians’ point of view), time taken to obtain results (rank-sum testing), specificity
and Kappa statistics of the two methods.
Results: The modified REMA, which is a one-step procedure, was found to be simpler to perform and results
were obtained in a significantly shorter time (5 versus 9 days, p <0.0001) compared to the classic REMA due
to addition of indicator and strain at the same time. The specificity of the modified REMA was low {46.8%
(35.5% - 58.4%) for RIF and 13.9% (7.2% - 23.5%) for INH}. Kappa statistics were 16.0% for RIF and 2.0%
for INH. Low specificity and kappa statistics are due to indicator reduction by the strains before complete
drug activity.
Conclusion: Although modified REMA is faster and simpler compared to classic REMA, it is not reliable for
MTB drug susceptibility testing.
Background
The global emergence of drug resistant tuberculosis (DR-
TB) underscores the need for rapid detection of drug resist-
ance. Standard agar proportion methods are accurate and
low-cost, but take weeks to obtain a result. The GeneXpert
MTB/RIF molecular assay [1], which has been endorsed by
World Health Organization (WHO) [2], is sensitive, rapid
and relatively easy to use. However, it remains costly in
resource-limited settings [3,4].
Colorimetric methods of drug susceptibility testing pro-
duce results more quickly than standard culture methods
[5] and are less costly than molecular methods [2]. For ex-
ample, the resazurin microtiter assay (REMA), which relies
on an oxidation-reduction reaction to induce a blue to
pink color change in the presence of live bacteria [6-8],
was endorsed by WHO for Mycobacterium tuberculosis
(MTB) drug sensitivity testing (DST) [2]. Sarker et al.
have proposed a modification of the classic REMA, to
simplify procedures and enable more rapid suscepti-
bility results [9]. The modified REMA shortens the
protocol by addition of the isolate and redox indica-
tors at the same time, and has been validated for
Staphylococcus aureus.H o w e v e r ,i th a sn o tb e e ne v a l -
uated for detection of drug resistance with MTB. We
evaluated the performance of the modified REMA for
detecting isoniazid (INH) and rifampicin (RIF) suscep-
tibility of MTB strains, using the classic REMA as the
reference standard.
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We tested archived MTB strains from the National
Tuberculosis Reference Laboratory in Kampala, and
Epicentre Mbarara Research Centre in Mbarara, Uganda.
MTB strains were grown in Middlebrook 7H9 broth
(Difco Laboratories, MI, USA) 70 supplemented with 10%
albumin– dextrose complex, 0.5% (v/v) glycerol and 0.1%
(w/v) casitone and diluted 1:10 of 1.0 McFarland turbidity
using Middlebrook 7H9-S broth [10].
We first defined the genetic identity and drug suscep-
tibility for the strains using the MTBDR-Plus Version 2
(HAIN Lifescience, Nehren Germany). We then grew the
strains with REMA reagents using both the classic REMA
and modified REMA methods. For the classic REMA,
we followed standard protocols, as described previously
[7,11,12]. Briefly, we incubated the strain-drug mixtures at
37°C for seven days, then added 0.02% resazurin indicator
and recorded any color changes (from blue to pink) after
48 hours. In contrast, for the modified REMA [9], we
added the strain, drugs and indicator (0.02%) at the same
time, incubated at 37°C, and assessed for color changes
daily. We measured minimum inhibitory concentrations
(MICs) of INH and RIF (Sigma-Aldrich, Milwaukee, WI,
USA) [10] by serially diluting the drugs. We defined the
MIC for each strain as the lowest concentration of a drug
that had no color change (Figure 1). Laboratory techni-
cians recorded data on time taken from culture to DST
results.
We categorized strains as sensitive or resistant to RIF
and INH by MIC thresholds of ≤0.5 and >0.5; and ≤0.25
and >0.25, respectively [10]. We calculated the sensitivity
and specificity of INH and RIF DST by the modified
REMA, comparing it to the classic REMA and Hain
MTBDR-Plus assays as the reference standards. We also
compared paired MIC results of the classic and modified
REMA using kappa testing. Finally, we compared time
from culture to DST results between the classic and modi-
fied REMA tests using non-parametric rank-sum testing.
Figure 1 A REMA plate showing color change.
Table 1 Diagnostic accuracy of the classic and modified
resazurin microtiter assay versus the MTBDR Plus Hain
assay for detection of drug resistant Mycobacterium
tuberculosis
Sensitivity Specificity
x/y (%) 95% CI x/y (%) 95% CI
RIF
Classic REMA 2/2 (100) 15.8 - 100 79/79 (100) 95.4 - 100
Modified REMA 2/2 (100) 15.8 - 100 37/79 (46.8) 35.5 - 58.4
INH
Classic REMA 2/2 (100) 15.8 - 100 79/79 (100) 95.4 - 100
Modified REMA 2/2 (100) 15.8 - 100 11/79 (13.9) 7.2 - 23.5
RIF: rifampicin: INH- isoniazid; REMA: resazurin microtiter assay.
Table 2 Paired comparison of minimum inhibitor
concentrations of Rifampicin for the modified and classic
resazurin microtiter assays for detection of drug
susceptibility in Mycobacterium tuberculosis
Rifampicin
Modified REMA MIC
MIC 0.0625 0.125 0.25 0.5 1 2 ≥4
Classic REMA MIC 0.0625 6 4 6 4 4 1 2
0.125 2 0 0 9 2 1 1
0.25 1 0 1 3 2 0 8
0.5 0 0 0 1 2 0 19
10 0 0 0 1 0 0
20 0 0 0 0 1 0
≥40 0 00 0 0 0
κ= 0.16.
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The study was approved by the Institutional Review
Committee of Mbarara University of Science and Technol-
ogy (reference no. 14/09-12), and permission to conduct
the study was granted by Uganda National Council for
Science and Technology (ref. HS 1312).
All 81 strains tested were confirmed as MTB by the
MDR-TB Hain assay. Of these, 78 were susceptible to both
RIF and INH, one was mono resistant to RIF, one was
mono resistant to INH, and one was resistant to both INH
and RIF (MDR). Classic REMA results were in perfect
agreement with the MTBDR Plus Hain assay results.
Compared to classic REMA, sensitivity and specificity
of the modified REMA were 100% (2/2, 15.8-100) and
13.9% (11/79, 7.16-23.5) for INH, and 100% (2/2, 15.8-
100) and 46.8% (37/79, 35.5-58.4) for RIF (Table 1). Be-
cause the classic REMA and Hain assays were in perfect
agreement, our estimates were similar with both reference
standards. Comparative MIC results for the classic REMA
a n dm o d i f i e dR E M Af o rp a i r e dM T Bs t r a i n sw e r es i g n i f i -
cantly different for both RIF (k=0.16) (Table 2) and INH
(k=0.02) (Table 3). For the modified REMA assay, 30/81
(37%) and 64/81 (79%) strains grew in the maximum
concentration of rifampicin and isoniazid, respectively.
Laboratory technologists found the modified REMA sub-
jectively easier to perform compared to the classic REMA,
and modified REMA yielded faster results (median time
to results was 5 versus 9 days; P<0.0001).
In summary we found that the modified REMA is a
rapid and simple DST for MTB. Unfortunately, it has un-
acceptably poor specificity for detection of both RIF and
INH resistance, limiting its applicability. The poor per-
formance of the modified REMA can likely be explained
by the requirement to add all reagents simultaneously and
the slow growth patterns of MTB. Both INH and RIF pri-
marily target actively dividing cells in the log growth phase.
M T Bi ss l o wg r o w i n g ,t h e r e f o r e ,a d d i t i o no ft h ei n d i c a t o r
simultaneously with the drug might allow the enzymatic
reaction of the indicator before the antimycobacterial
agents have ample time to inhibit growth. Because the re-
duction of resazurin is an irreversible reaction [2,6] a sus-
ceptible strain may be falsely indicated as resistant. This
same phenomenon would not be expected to occur with
faster growing organisms with a shorter log phase, for ex-
ample, S. aureus. Thus, while reducing time to results, the
early mixing step likely contributes to low specificity. Al-
ternative manipulations of the classic REMA assay should
be pursued to help decrease time for DST results while en-
abling accurate results. In this study, we provide data to
suggest that the resazurin indicator does not inhibit MTB
growth, as has been previously speculated. Therefore, to
exploit the short time required to complete the modified
REMA assay, future work should evaluate its utility for
rapid diagnosis of TB from sputum samples, without a
focus on drug suceptibility.
Conclusion
Although modified REMA is faster and simpler than the
classic REMA, it is not reliable for MTB DST testing due
to poor specificity for detection of both INH and RIF resist-
ance. It should not be recommended as a DST for MTB,
although its utility as a rapid diagnostic test for MTB in
sputum samples should be further evaluated.
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